Tumour suppressor gene (TSG) silencing through promoter hypermethylation plays an important role in cancer initiation. The aim of this study was to assess the extent of methylation of APC gene promoter in 91 sporadic and 44 familial cases of Tunisian patients with breast cancer (BC) in. The frequency of APC promoter methylation is somewhat similar for sporadic and familial breast cancer cases, (52.1%, and 54.5% respectively). For sporadic breast cancer patients, there was a significant correlation of APC promoter hypermethylation with TNM stage (p = 0.024) and 3-year survival (p = 0.025). Regarding the hormonal status (HR), we found significant association between negativity to PR and unmethylated APC(p= 0.005) while ER and Her2/neu are not correlated. Moreover, unmethylated APC promoter is more frequent in tumours expressing at least one out the 3 proteins compared to triple negative cases (p= 0.053). On the other hand, aberrant methylation of APC was associated with tumour size (p = 0.036), lymph node (p = 0.028), distant metastasis (p = 0.031), and 3-year survival (p = 0.046) in the group of patients with familial breast cancer. Moreover, patients with sporadic breast cancer displaying the unmethylated profile have a significant prolonged overall survival compared to those with the methylated pattern of APC promoter (p log rank = 0.008). Epigenetic change at the CpG islands in the APC promoter was associated with the silence of its transcript and the loss of protein expression suggesting that this event is the main mechanism regulating the APC expression in breast cancer. In conclusion, our data showed that the loss of APC through aberrant methylation is associated with the aggressive behavior of both sporadic and familial breast cancer in Tunisian patients.
KinzlerKW, NilbertMC, SuLK, VogelsteinB, BryanTM, LevyDB, SmithKJ, PreisingerAC, HedgeP, McKechnieD. Identification of FAP locus genes from chromosome 5q21. Science, 253 (1991): 661-665.
2.
MoonRT, MillerJR. The APC tumour suppressor protein in development and cancer. Trends Genet, 13 (1997): 256-258.
3.
FearnheadNS, BrittonMP, BodmerWF. The ABC of APC. Hum Mol Genet, 10 (2001): 721-733.
4.
BodmerWF, BaileyCJ, BodmerJ, BusseyHJ, EllisA, GormanP, LucibelloFC, MurdayVA, RiderSH, ScamblerP. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature, 328 (1987): 614-616.
5.
GrodenJ, ThliverisA, SamowitzW, CarlsonM, GelbertL, AlbertsenH, JoslynG, StevensJ, SpirioL, RobertsonM. Identification and characterization of the familial adenomatous polyposis coli gene. Cell, 66 (1991): 589-600.
6.
JoslynG, CarlsonM, ThliverisA, AlbertsenH, GelbertL, SamowitzW, GrodenJ, StevensJ, SpirioL, RobertsonM. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell, 66 (1991): 601-613.
7.
NishishoI, NakamuraY, MiyoshiY, MikiY, AndoH, HoriiA, KoyamaK, UtsunomiyaJ, BabaS, HedgeP. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science, 253 (1991): 665-669.
8.
FearonER, VogelsteinB. A genetic model for colorectal tumourigenesis. Cell, 61 (1990): 759-767.
9.
MiyoshiY, NagaseH, AndoH, HoriiA, IchiiS, NakatsuruS, AokiT, MikiY, MoriT, NakamuraY. Somatic mutations of the APC gene in colorectal tumours: mutation cluster region in the APC gene. Hum Mol Genet, 1 (1992): 229-233.
10.
PowellSM, ZilzN, Beazer-BarclayY, BryanTM, HamiltonSR, ThibodeauSN, VogelsteinB, KinzlerKWl. APC mutations occur early during colorectal tumourigenesis. Nature, 359 (1992): 235-237.
11.
HoKY, KalleWH, LoTH, LamWY, TangCM. Reduced expression of APC and DCC gene protein in breast cancer. Histopathology, 35 (1999): 249-256.
12.
JönssonM, BorgA, NilbertM, AnderssonT. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer. Eur J Cancer, 36 (2000): 242-248.
13.
SchlosshauerPW, BrownSA, EisingerK, YanQ, GuglielminettiER, ParsonsR, EllensonLH, KitajewskiJ. APC truncation and increased beta-catenin levels in a human breast cancer cell line. Carcinogenesis, 21 (2000): 1453-1456.
14.
FuruuchiK, TadaM, YamadaH, KataokaA, FuruuchiN, HamadaJ, TakahashiM, TodoS, MoriuchiT. Somatic mutations of the APC gene in primary breast cancers. Am J Pathol, 156 (2000): 1997-2005.
15.
ThompsonAM, MorrisRG, WallaceM, WyllieAH, SteelCM, CarterDC. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer, 68 (1993): 64-68.
16.
MedeirosAC, NagaiMA, NetoMM, BrentaniRR. Loss of heterozygosity affecting the APC and MCC genetic loci in patients with primary breast carcinomas. Cancer Epidemiol Biomarkers Prev, 3 (1994): 331-333.
17.
BirgisdottirV, StefanssonOA, BodvarsdottirSK, HilmarsdottirH, JonassonJG, EyfjordJE. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res, 8 (2006): R38.
18.
LambertzS, BallhausenWG. Identification of an alternative 5' untranslated region of the adenomatous polyposis coli gene. Hum Genet, 90 (1993): 650-652.
19.
EstellerM, SparksA, ToyotaM, Sanchez-CespedesM, CapellaG, PeinadoMA, GonzalezS, TarafaG, SidranskyD, MeltzerSJ, BaylinSB, HermanJG. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res, 60 (2000): 4366-43.
20.
TsuchiyaT, TamuraG, SatoK, EndohY, SakataK, JinZ, MotoyamaT, UsubaO, KimuraW, NishizukaS, WilsonKT, JamesSP, YinJ, FleisherAS, ZouT. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene, 19 (2000): 3642-3646.
LairdPW. The power and the promise of DNA methylation markers. Nat Rev Cancer, 3 (2003): 253-266.
25.
ChomczynskiP, SacchiN. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162 (1987): 156-159.
26.
Karray-ChouayekhS, TrifaF, KhabirA, BoujelbaneN, Sellami-BoudawaraT, DaoudJ, FrikhaM, GargouriA, Mokdad-GargouriR. Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma. J Biomed Biotechnol, (2009) 369129.
27.
Karray-ChouayekhS, TrifaF, KhabirA, BoujelbaneN, Sellami-BoudawaraT, DaoudJ, FrikhaM, GargouriA, Mokdad-GargouriR. Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma. J Biomed Biotechnol, (2009): 369129.
28.
MunemitsuS, AlbertI, SouzaB, RubinfeldB, PolakisP. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumour-suppressor protein. Proc Natl Acad Sci USA, 92 (1995): 3046-3050.
AberleH, BaueA, StappertJ, KispertA, KemlerR. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J, 16 (1997): 3797-3804.
31.
CleversH. Wnt/beta-catenin signaling in development and disease. Cell, 127 (2006): 469-480.
32.
DulaimiE, HillinckJ, Ibanez de CaceresI, Al-SaleemT, CairnsP. Tumour suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res, 10 (2004): 6189-6193.
33.
LewisCM, ClerLR, BuDW, Zöchbauer-MüllerS, MilchgrubS, NaftalisEZ, LeitchAM, MinnaJD, EuhusDM. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res, 11 (2005): 166-172.
34.
PrasadCP, MirzaS, SharmaG, PrashadR, DattaGuptaS, RathG, RalhanR. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci, 83 (2008): 318-325.
35.
Van der AuweraI, Van LaereSJ, Van den BoschSM, Van den EyndenGG, TrinhBX, van DamPA, ColpaertCG, van EngelandM, Van MarckEA, VermeulenPB, DirixLY. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. Br J Cancer, 99 (2008): 1735-1742.
36.
HachanaM, TrimecheM, ZiadiS et al. Evidence for a role of the Simian Virus 40 in human breast carcinomas. Breast Cancer Res Treat, 113 (2009): 43-58
37.
XuX, GammonMD, ZhangY, AmaraK, KorbiS. Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat, 121 (2010): 685-692.
38.
UsadelH, BrabenderJ, DanenbergKD, JerónimoC, HardenS, EnglesJ, DanenbergPV, YangS, SidranskyD. Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res, 62 (2002): 371-375.
39.
YangHJ, LiuVW, WangY, ChanKY, TsangPC, KhooUS, CheungAN, NganHY. Detection of hypermethylated genes in tumour and plasma of cervical cancer patients. Gynecologic Oncol, 93 (2004): 435-440.
40.
SwellamM, AbdelmaksoudMD, Sayed MahmoudM, RamadanA, Abdel-MoneemW, HefnyMM. Aberrant methylation of APC and RARβ 2 genes in breast cancer patients. IUBMB Life, 67 (2015): 61-68.
